With regard to Health Canada, Sandoz Canada and the most recent drug shortage: (a) what were the latest inspection reports by Health Canada regarding Sandoz Canada and its Boucherville plant in particular; (b) although the U.S. Food and Drug Administration (FDA) required Sandoz to improve several production lines at its Boucherville plant, did Health Canada consider this plant to be sufficiently safe; (c) what correspondence did Health Canada and the FDA exchange regarding Sandoz or injection drugs between April 1, 2011, and March 12, 2012; (d) did Health Canada receive a notice from the FDA or Sandoz following the FDA’s visit to Sandoz in August of 2011; (e) did Health Canada receive a copy of the letter from the FDA to Sandoz Canada on November 18, 2011; and (f) if so, when did Health Canada receive this letter?
In the House of Commons on April 30th, 2012. See this statement in context.